KARBE FRANK 4
4 · Better Therapeutics, Inc. · Filed Jul 7, 2022
Insider Transaction Report
Form 4
KARBE FRANK
DirectorSee Remarks
Transactions
- Award
Stock Option (Right to Buy)
2022-07-05+472,200→ 472,200 totalExercise: $1.68Exp: 2032-07-04→ Common Stock (472,200 underlying)
Footnotes (1)
- [F1]The stock option vests as to 1/4 of the shares subject to the stock option on July 5, 2023 and the remaining shares vest in 36 equal monthly installments thereafter, provided the Reporting Person continues to have a service relationship with Issuer on each vesting date. The stock option was granted on July 5, 2022.